Mahieu H F
Department of Otorhinolaryngology, Meander Medical Centre, Amersfoort, The Netherlands.
Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:17-24. doi: 10.1111/j.1365-2036.2007.03474.x.
Despite increasing clinical and experimental evidence of its existence, otolaryngological manifestations of reflux disease remain controversial, concerning diagnosis as well as treatment.
Proper understanding of laryngopharyngeal reflux disease (LPRD).
Review of literature.
Scepticism concerning LPRD is based upon differences between gastro-oesophageal reflux disease and LPRD; lack of specificity and sensitivity of diagnostic tests to confirm LPRD; non-specificity of laryngological symptoms, which are difficult to distinguish from other causes of upper respiratory tract inflammation; non-specificity of laryngological signs in laryngoscopy, with high intra- and inter-observer variability in evaluation; diagnosis of LPRD is essentially only based on a combination of diagnostic signs and symptoms, which cannot be attributed to other pathology; slow, or sometimes lack of, response of LPRD symptoms to proton pump inhibitor (PPI) medication and lack of evidence concerning efficacy of PPIs in placebo-controlled trials.
LPRD remains a diagnosis by exclusion and resolution of symptoms following 4-month trial of 40 mg PPI twice daily is, for all practical purposes, considered proof of the initial diagnosis. However, non-response does not exclude LPRD as PPIs have no influence on noxious non-acid components of the refluxate.
尽管临床和实验证据越来越多地证明反流病的存在,但反流病的耳鼻喉科表现,在诊断和治疗方面仍存在争议。
正确认识喉咽反流病(LPRD)。
文献综述。
对LPRD持怀疑态度的依据包括:胃食管反流病与LPRD之间存在差异;用于确诊LPRD的诊断测试缺乏特异性和敏感性;喉科症状不具特异性,难以与上呼吸道炎症的其他病因相区分;喉镜检查中的喉科体征不具特异性,观察者内部和观察者之间在评估时的变异性很大;LPRD的诊断基本上仅基于诊断体征和症状的组合,且这些体征和症状不能归因于其他病理情况;LPRD症状对质子泵抑制剂(PPI)药物治疗反应缓慢,有时甚至没有反应,且在安慰剂对照试验中缺乏PPI疗效的证据。
LPRD仍然是一种排除性诊断,对于所有实际目的而言,每天两次服用40毫克PPI进行4个月试验后症状缓解,被视为初步诊断的证据。然而,无反应并不排除LPRD,因为PPI对反流物中有害的非酸性成分没有影响。